130 related articles for article (PubMed ID: 3953616)
21. The effect of cold exposure on diffusing capacity in patients with Raynaud's phenomenon.
Wise RA; Wigley F; Newball HH; Stevens MB
Chest; 1982 Jun; 81(6):695-8. PubMed ID: 7075304
[TBL] [Abstract][Full Text] [Related]
22. Effects of long-term cyclic iloprost therapy in systemic sclerosis with Raynaud's phenomenon. A randomized, controlled study.
Scorza R; Caronni M; Mascagni B; Berruti V; Bazzi S; Micallef E; Arpaia G; Sardina M; Origgi L; Vanoli M
Clin Exp Rheumatol; 2001; 19(5):503-8. PubMed ID: 11579708
[TBL] [Abstract][Full Text] [Related]
23. Comparative assessment of the effects of vasodilators on peripheral vascular reactivity in patients with systemic scleroderma and Raynaud's phenomenon: color Doppler flow imaging study.
Aikimbaev KS; Oğuz M; Ozbek S; Demirtaş M; Birand A; Batyraliev T
Angiology; 1996 May; 47(5):475-80. PubMed ID: 8644944
[TBL] [Abstract][Full Text] [Related]
24. [Action of nifedipine on the post-ischemic cold hyperemia reaction in Raynaud's phenomenon].
Vayssairat M; Blaison N; Baudot N; Evenou P; Gilard M; Mathieu JF
J Mal Vasc; 1989; 14(4):299-302. PubMed ID: 2584886
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary vascular response during Raynaud's phenomenon in progressive systemic sclerosis.
Shuck JW; Oetgen WJ; Tesar JT
Am J Med; 1985 Feb; 78(2):221-7. PubMed ID: 3970048
[TBL] [Abstract][Full Text] [Related]
26. Prevention by nifedipine of cold pressor-induced decrease in left ventricular ejection fraction.
Goldhaber SZ; White HD; Holman BL; Nesto RW; Mudge GH; Muller JE; Kozlowski J; Wynne J
J Am Coll Cardiol; 1983 Jun; 1(6):1512-7. PubMed ID: 6304176
[TBL] [Abstract][Full Text] [Related]
27. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
[TBL] [Abstract][Full Text] [Related]
28. Nifedipine in Raynaud's phenomenon: relationship between immediate, short term and longterm effects.
Kallenberg CG; Wouda AA; Kuitert JJ; Tijssen J; Wesseling H
J Rheumatol; 1987 Apr; 14(2):284-90. PubMed ID: 3598997
[TBL] [Abstract][Full Text] [Related]
29. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders.
Maricq HR; Weinrich MC; Valter I; Palesch YY; Maricq JG
J Rheumatol; 1996 Dec; 23(12):2068-78. PubMed ID: 8970043
[TBL] [Abstract][Full Text] [Related]
30. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
31. Cardiopulmonary hemodynamics in systemic sclerosis and response to nifedipine and captopril.
Sfikakis PP; Kyriakidis MK; Vergos CG; Vyssoulis GP; Psarros TK; Kyriakidis CA; Mavrikakis ME; Sfikakis PP; Toutouzas PK
Am J Med; 1991 May; 90(5):541-6. PubMed ID: 2029011
[TBL] [Abstract][Full Text] [Related]
32. [Systemic scleroderma in children].
Plantin P; Gavanou J; Le Fur JM; Guillet G
Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
[TBL] [Abstract][Full Text] [Related]
33. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.
Engelhart M; Seibold JR
Angiology; 1990 Sep; 41(9 Pt 1):715-23. PubMed ID: 2221472
[TBL] [Abstract][Full Text] [Related]
34. Nifedipine and Raynaud's phenomenon associated with connective tissue diseases.
Kahan A; Weber S; Amor B; Menkes CJ; Hodara M; Degeorges M
Int Angiol; 1985; 4(2):221-3. PubMed ID: 3831143
[TBL] [Abstract][Full Text] [Related]
35. [Esophageal motility in Raynaud's disease, systemic scleroderma and presclerodermal Raynaud's syndrome].
Hostein J; Bost R; Carpentier P; Franco A; Fournet J
Gastroenterol Clin Biol; 1985 Feb; 9(2):130-5. PubMed ID: 3979734
[TBL] [Abstract][Full Text] [Related]
36. Autonomic neuropathy in systemic sclerosis.
Klimiuk PS; Taylor L; Baker RD; Jayson MI
Ann Rheum Dis; 1988 Jul; 47(7):542-5. PubMed ID: 3401050
[TBL] [Abstract][Full Text] [Related]
37. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
Finch MB; Dawson J; Johnston GD
Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096
[TBL] [Abstract][Full Text] [Related]
38. Effects of low-dose nifedipine on a cold provocation test in patients with Raynaud's disease.
Weber A; Bounameaux H
J Cardiovasc Pharmacol; 1990 May; 15(5):853-5. PubMed ID: 1692948
[TBL] [Abstract][Full Text] [Related]
39. Role of cold and emotional stress in Raynaud's disease and scleroderma.
Freedman RR; Ianni P
Br Med J (Clin Res Ed); 1983 Nov; 287(6404):1499-502. PubMed ID: 6416474
[TBL] [Abstract][Full Text] [Related]
40. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
Serri J; Legré R; Veit V; Guardia C; Gay AM
Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
